EP16.03-012 Novel Human-derived EML4-ALK Fusion cell lines identify ribonucleotide reductase RRM2 as a Target of Activated ALK in NSCLC
- Resource Type
- Abstract
- Source
- In
Journal of Thoracic Oncology September 2022 17(9) Supplement:S591-S591 - Subject
- Language
- ISSN
- 1556-0864